Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

New research suggests that psilocybin shifts the brain from a relaxed state into a highly engaged pattern of rapid electrical ...

Four years after Russia launched its full-scale invasion, Ukraine faces a growing mental health crisis. Some with severe PTSD ...

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...

Hannah-Grace's life hanged in the balance following the accident in the first week of 2026 that cut short the life of her devoted father and left her mother with an injured arm and a badly swollen eye ...

I have never met a successful leader who is fearless. Rather, they've learned how to harness fear. They listen to it, prepare ...

Modern work is testing the limits of the human mind. We operate in an environment defined by constant notifications, relentless context-switching and accelerating expectations, yet our brains are ...

AtaiBeckley is a clinical-stage psychedelic biotech targeting TRD and SAD, with BPL-003 as its lead value driver. Learn more about ATAI stock here.

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...

Many people believe intelligence is a fixed trait you receive at birth and cannot change. Scientific discoveries paint a completely different picture of how the human brain actually works. Your ...

Explore neuroscience breakthroughs reshaping treatments for Alzheimer’s, Parkinson’s, PTSD, and other brain disorders.

In the historical context, psychedelics reveal a spectrum of applications, ranging from spiritual and recreational use to ...